manufacturing

News

Lilly pauses COVID-19 antibody trial after factory hits trou...

Eli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found serious quality control problems at the plant, according to press reports.

News

BioNTech, Lilly shore up manufacturing capacity for their CO...

With vaccines and drugs for COVID-19 now in late-stage development, companies are moving swiftly to lay down the capacity to make them at scale, as new deals for BioNTech and Eli Lilly this

News

Sanofi set to spin off API business late next year - report

Sanofi is to begin preparations in autumn to spin off its active ingredients business and is lining up a potential stock market launch by 2022, according to a press report.

News

Gilead working with generics firms to boost global supply of...

Gilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet global demand.

News

Coronavirus has caused drug shortage, says FDA chief

The FDA has announced the first drug shortage caused by the COVID-19 coronavirus outbreak, following previous warnings about its impact on the drug supply chain.

News

Shanghai/China-Jan.2020: New type coronavirus pneumonia in Wuhan has been spreading many cities in China. People wearing surgical mask sitting in subway in Shanghai

COVID-19 could disrupt supplies of cheap generics, analysts ...

An extended COVID-19 coronavirus outbreak could impact on supplies of generic drugs that many health systems rely on to keep costs as low as possible, according to a new report from ratings

Lilly pauses COVID-19 antibody trial after factory hits trou...

BioNTech, Lilly shore up manufacturing capacity for their CO...

Sanofi set to spin off API business late next year - report

Gilead working with generics firms to boost global supply of...

Coronavirus has caused drug shortage, says FDA chief

COVID-19 could disrupt supplies of cheap generics, analysts ...

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

manufacturing

Editor's Picks